Squamous cell carcinoma (SqCC) is the second most prevalent type of lung cancer. However, treatment options for these patients remain limited and have remained largely unchanged over decades. Now, a new study by researchers at the Garvan Institute of Medical Research has identified molecular profiles of the surrounding matrix of squamous cell carcinoma that might indicate which patients are likely to develop aggressive tumors.
Their findings, “Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma,” are published in the journal BMC Genome Medicine.
